These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

166 related items for PubMed ID: 15523233

  • 1. [Imatinib mesylate-induced acute cytolytic hepatitis].
    Rocca P, El Jastimi S, Troncy J, Scoazec JY, Boucher A, Vial T, Trépo C, Zoulim F.
    Gastroenterol Clin Biol; 2004 Oct; 28(10 Pt 1):918-9. PubMed ID: 15523233
    [No Abstract] [Full Text] [Related]

  • 2. Histological features of acute hepatitis after imatinib mesylate treatment.
    James C, Trouette H, Marit G, Cony-Makhoul P, Mahon FX.
    Leukemia; 2003 May; 17(5):978-9. PubMed ID: 12750713
    [No Abstract] [Full Text] [Related]

  • 3. [Fulminating hepatitis for imatinib in a patient with chronic myeloid leukaemia].
    Martínez Pascual C, Valdés Mas M, de la Peña Moral JM, Miras López M.
    Med Clin (Barc); 2011 Sep 17; 137(7):329-30. PubMed ID: 21074222
    [No Abstract] [Full Text] [Related]

  • 4. Successful management of liver injury caused by imatinib mesylate in a patient with previously untreated chronic myelogenous leukemia in the chronic phase.
    Yamazaki R, Okamoto S, Chen CK, Tada S, Saito H, Shibata R, Sakamoto M, Mori T, Ikeda Y.
    Leuk Lymphoma; 2006 Jul 17; 47(7):1427-30. PubMed ID: 16923586
    [No Abstract] [Full Text] [Related]

  • 5. Nilotinib in a patient with postnecrotic liver cirrhosis related to imatinib.
    Spataro V.
    J Clin Oncol; 2011 Jan 20; 29(3):e50-2. PubMed ID: 20956624
    [No Abstract] [Full Text] [Related]

  • 6. Imatinib mesylate: a new pill for chronic myelogenous leukemia.
    Parmar KK, King RS.
    Cancer Pract; 2001 Jan 20; 9(5):263-5. PubMed ID: 11879324
    [No Abstract] [Full Text] [Related]

  • 7. Pigmentary changes in chronic myeloid leukemia patients treated with imatinib mesylate.
    Arora B, Kumar L, Sharma A, Wadhwa J, Kochupillai V.
    Ann Oncol; 2004 Feb 20; 15(2):358-9. PubMed ID: 14760137
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Imatinib mesylate induced immune thrombocytopenia.
    Rajappa S, Varadpande L, Paul TR, Digumarti R.
    Leuk Lymphoma; 2007 Nov 20; 48(11):2261-3. PubMed ID: 17926182
    [No Abstract] [Full Text] [Related]

  • 10. Early imatinib-mesylate-induced hepatotoxicity in chronic myelogenous leukaemia.
    Kong JH, Yoo SH, Lee KE, Nam SH, Kwon JM, Lee SM, Chang HJ, Choi MY, Cho MS, Mun YC, Nam E, Lee SN, Seong CM.
    Acta Haematol; 2007 Nov 20; 118(4):205-8. PubMed ID: 18030002
    [Abstract] [Full Text] [Related]

  • 11. Imatinib mesylate.
    Am J Health Syst Pharm; 2001 Dec 01; 58(23):2241-2. PubMed ID: 11765724
    [No Abstract] [Full Text] [Related]

  • 12. [Survival following liver transplant due to imatinib-induced acute liver failure: a case study].
    García-Valdés M, Miras López M, Garrido Corro B, De La Rubia Nieto A.
    Farm Hosp; 2012 Dec 01; 36(1):50-1. PubMed ID: 21514865
    [No Abstract] [Full Text] [Related]

  • 13. Precipitation of porphyria cutanea tarda by imatinib mesylate?
    Ho AY, Deacon A, Osborne G, Mufti GJ.
    Br J Haematol; 2003 Apr 01; 121(2):375. PubMed ID: 12694262
    [No Abstract] [Full Text] [Related]

  • 14. Unusual fluid retention with imatinib therapy for chronic myeloid leukemia.
    Ostro D, Lipton J.
    Leuk Lymphoma; 2007 Jan 01; 48(1):195-6. PubMed ID: 17325868
    [No Abstract] [Full Text] [Related]

  • 15. Imatinib-induced nail hyperpigmentation in chronic myeloid leukemia.
    Prabhash K, Biswas G, Prasad N, Karant N, Sastry PS, Parikh PM.
    Indian J Dermatol Venereol Leprol; 2006 Jan 01; 72(1):63-4. PubMed ID: 16481719
    [No Abstract] [Full Text] [Related]

  • 16. Gleevec: tailoring to fit.
    May TS.
    Drug Discov Today; 2003 Mar 01; 8(5):188-9. PubMed ID: 12634004
    [No Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Leukemia. Q&A highlights.
    Frame D, Sessions J, Fausel C.
    Am J Health Syst Pharm; 2007 Dec 15; 64(24 Suppl 15):S22. PubMed ID: 18056929
    [No Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. A patient of chronic myelogenous leukemia developing painful rash on feet.
    Kumar P, Das NK, Sil A, Chakrabarti P.
    J Postgrad Med; 2012 Dec 15; 58(4):331-4. PubMed ID: 23298941
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 9.